Drugs / Neoantigen Dendritic Cell Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04912765 | Apr 2021 → Dec 2026 expected | colorectal carcinoma, hepatocellular carcinoma, metastasis from malignant tumor of colon | National Cancer Centre, Singapore | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neoantigen Dendritic Cell Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04912765 ↗ |
| Modality | Vaccine | “NA DC vaccine” NCT04912765 ↗ |
| Route | Other | “via intra-dermal injection” NCT04912765 ↗ |